AD-Related Pathology and Gray Matter Atrophy Rates in Probable Dementia with Lewy Bodies (P6.232)
Lidia Sarro(Fondazione IRCCS Istituto Neurologico Carlo Besta), Kejal Kantarci(Mayo Clinic in Arizona), Clifford R. Jack(Mayo Clinic), Ronald Petersen(Mayo Clinic in Arizona), Scott A. Przybelski(Mayo Clinic in Florida), Val J. Lowe(Mayo Clinic), Matthew L. Senjem(Mayo Clinic in Florida), Timothy G. Lesnick(Mayo Clinic in Florida), David S. Knopman(Mayo Clinic), Emily S. Lundt(Mayo Clinic in Florida), Bradley Boeve(Mayo Clinic in Arizona), Massimo Filippi(Vita-Salute San Raffaele University)
Cited by 0
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k